These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22464564)

  • 21. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
    Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
    Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nerve size correlates with clinical severity in Charcot-Marie-Tooth disease 1A.
    Zanette G; Tamburin S; Taioli F; Lauriola MF; Badari A; Ferrarini M; Cavallaro T; Fabrizi GM
    Muscle Nerve; 2019 Dec; 60(6):744-748. PubMed ID: 31469427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel GJB1 mutation in an Italian patient with Charcot-Marie-Tooth disease and pyramidal signs.
    Luigetti M; Fabrizi GM; Ranieri F; Taioli F; Conte A; Del Grande A; Sabatelli M
    Muscle Nerve; 2011 Oct; 44(4):613-5. PubMed ID: 21922480
    [No Abstract]   [Full Text] [Related]  

  • 24. Unusual electrophysiological findings in X-linked dominant Charcot-Marie-Tooth disease.
    Gutierrez A; England JD; Sumner AJ; Ferer S; Warner LE; Lupski JR; Garcia CA
    Muscle Nerve; 2000 Feb; 23(2):182-8. PubMed ID: 10639608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Charcot-Marie-Tooth type X: A novel mutation in the Cx32 gene with central conduction slowing.
    Seeman P; Mazanec R; Ctvrtecková M; Smilková D
    Int J Mol Med; 2001 Oct; 8(4):461-8. PubMed ID: 11562788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Charcot-Marie-Tooth disease. Electromyographic studies in 45 patients].
    Freitas MR; Nascimento OJ; Nevares MT; Escada TM
    Arq Neuropsiquiatr; 1995 Sep; 53(3-B):552-9. PubMed ID: 8585810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy.
    Killian JM; Tiwari PS; Jacobson S; Jackson RD; Lupski JR
    Muscle Nerve; 1996 Jan; 19(1):74-8. PubMed ID: 8538673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
    Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
    Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Charcot-Marie-Tooth disease subtypes and genetic testing strategies.
    Saporta AS; Sottile SL; Miller LJ; Feely SM; Siskind CE; Shy ME
    Ann Neurol; 2011 Jan; 69(1):22-33. PubMed ID: 21280073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological features of Hirayama disease.
    Lyu RK; Huang YC; Wu YR; Kuo HC; Ro LS; Chen CM; Chang HS
    Muscle Nerve; 2011 Aug; 44(2):185-90. PubMed ID: 21755506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anomalous intrinsic hand muscle innervation in median and ulnar nerve lesions: an electrophysiological study.
    Uncini A; Lange DJ; Lovelace RE
    Ital J Neurol Sci; 1988 Oct; 9(5):497-503. PubMed ID: 3215751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.
    Miltenberger-Miltenyi G; Janecke AR; Wanschitz JV; Timmerman V; Windpassinger C; Auer-Grumbach M; Löscher WN
    Arch Neurol; 2007 Jul; 64(7):966-70. PubMed ID: 17620486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uniform slowing of conduction velocities in Charcot-Marie-Tooth polyneuropathy type 1.
    Kaku DA; Parry GJ; Malamut R; Lupski JR; Garcia CA
    Neurology; 1993 Dec; 43(12):2664-7. PubMed ID: 8255473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late onset axonal Charcot-Marie-Tooth phenotype caused by a novel myelin protein zero mutation.
    Bienfait HM; Faber CG; Baas F; Gabreëls-Festen AA; Koelman JH; Hoogendijk JE; Verschuuren JJ; Wokke JH; de Visser M
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):534-7. PubMed ID: 16543539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel GARS mutation presenting as autosomal dominant intermediate Charcot-Marie-Tooth disease.
    Nan H; Takaki R; Hata T; Ichinose Y; Tsuchiya M; Koh K; Takiyama Y
    J Peripher Nerv Syst; 2019 Mar; 24(1):156-160. PubMed ID: 30394614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible inflammatory neuropathy superimposed on Charcot-Marie-Tooth type 1A disease.
    Gazulla J; Almárcegui C; Berciano J
    Neurol Sci; 2018 Apr; 39(4):793-794. PubMed ID: 29164357
    [No Abstract]   [Full Text] [Related]  

  • 37. A Review of X-linked Charcot-Marie-Tooth Disease.
    Wang Y; Yin F
    J Child Neurol; 2016 May; 31(6):761-72. PubMed ID: 26385972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medial thenar recording in normal subjects and carpal tunnel syndrome.
    Wilder Smith EP; Chan YH; Kannan TA
    Clin Neurophysiol; 2007 Apr; 118(4):757-61. PubMed ID: 17307031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The electrophysiological profile of hereditary motor and sensory neuropathy-Lom.
    Ishpekova BA; Christova LG; Alexandrov AS; Thomas PK
    J Neurol Neurosurg Psychiatry; 2005 Jun; 76(6):875-8. PubMed ID: 15897517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotype of Charcot-Marie-Tooth disease Type 2.
    Bienfait HM; Baas F; Koelman JH; de Haan RJ; van Engelen BG; Gabreëls-Festen AA; Ongerboer de Visser BW; Meggouh F; Weterman MA; De Jonghe P; Timmerman V; de Visser M
    Neurology; 2007 May; 68(20):1658-67. PubMed ID: 17502546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.